Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPhoenix Group Holdings Regulatory News (PHNX)

  • There is currently no data for PHNX

Board Changes

25 Aug 2016 07:00

RNS Number : 0802I
Phoenix Group Holdings
25 August 2016
 

 

Phoenix Group Holdings - Board Changes

 

The Board of Phoenix Group Holdings ("Phoenix") is pleased to announce the appointments of three new non-executive directors, Wendy Mayall, John Pollock and Nicholas Shott, all with effect from 1 September 2016.

 

Wendy Mayall has over thirty years' asset management experience, including as Group Chief Investment Officer and latterly consultant at Liverpool Victoria from 2012 to 2015, having previously been Chief Investment Officer for Unilever's UK pension fund from 1996 to 2011 and holding management responsibility for Unilever's pension funds globally. From 2006 to 2009, she was the Chair of the Investment Committee of the Mineworkers Pension Scheme, a British government appointment to one of the largest government backed pension schemes in the UK. Mrs Mayall is the non-executive Senior Independent Director of the Aberdeen UK Tracker Trust plc.

 

John Pollock had a highly successful career in life assurance at the Legal & General Group from 1980 to 2015, including as an executive director of Legal & General Group plc from 2003 to 2015. He held numerous senior roles, gaining wide strategic and technical experience, finally as Chief Executive Officer of LGAS (L&G Assurance Society), one of Legal and Generals' three primary business units, employing 6,000 staff. His previous roles included Chief Executive Officer (Protection and Annuities). Prior to his retirement from Legal and General in 2015, Mr Pollock held positions as Deputy Chair of the FCA Practitioner Panel, Chairman of investment platform Cofunds, and as a non-executive director of the Cala Homes Group.

 

Nicholas Shott is a highly experienced investment banker, who is European Vice Chairman of Lazard, a role he has held since 2007, and Head of UK Investment Banking at Lazard, which he has been since 2009. He joined Lazard in 1991 and became a partner in 1997. His wide experience of successfully advising clients on M&A deals in various sectors over many years is expected to be of significant benefit to Phoenix in pursuing its acquisition strategy.

 

The Phoenix Board also announces that Rene-Pierre Azria will be leaving the Board on 30 November 2016 after seven years as a non-executive director.

 

Commenting on the Board changes, Henry Staunton, Phoenix Chairman said: "I am delighted that we have secured the appointments to the Phoenix Board of three such experienced and successful individuals who will enhance the Board skillset in both quality and diversity. I would like to thank Rene-Pierre Azria for his valuable contribution to Phoenix since his appointment to the Board in September 2009 and through its progress as a premium listed company from July 2010. On behalf of all the Board, I wish him well."

 

No other information is required to be notified under Listing Rule 9.6.13 R.

 

Enquiries:

MediaNeil Bennett, MaitlandPeter Ogden, Maitland+ 44 (0) 20 7379 5151

InvestorsSam Perowne, Head of Investor Relations, Phoenix Group+44 (0) 203 735 0021

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPIMLTMBITBBF
Date   Source Headline
3rd Jul 20233:30 pmRNSTotal Voting Rights
30th Jun 202311:30 amRNSPublication of a Prospectus
16th Jun 20233:01 pmRNSDirector Declaration
12th Jun 20231:30 pmRNSBlock Listing Return
7th Jun 20238:38 amRNSDirector/PDMR Shareholding
1st Jun 20231:24 pmRNSBlock Listing Application
1st Jun 20231:00 pmRNSTotal Voting Rights
16th May 202312:10 pmRNSDirector/PDMR Shareholding
11th May 20236:00 pmRNSDirectorate Change
10th May 20234:06 pmRNSDirector/PDMR Shareholding
4th May 20233:35 pmRNSHolding(s) in Company
4th May 20232:19 pmRNSResult of AGM
2nd May 20233:00 pmRNSTotal Voting Rights
6th Apr 20233:00 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20235:30 pmRNSTotal Voting Rights
3rd Apr 20238:02 amRNSAcquisition
30th Mar 20232:00 pmRNSDirector/PDMR Shareholding
28th Mar 20234:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20233:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20235:45 pmRNSNotice of AGM
22nd Mar 20233:00 pmRNSDirector/PDMR Shareholding
20th Mar 20235:00 pmRNSDirector/PDMR Shareholding
15th Mar 20235:30 pmRNSDirector/PDMR Shareholding
13th Mar 20233:00 pmRNSDirector/PDMR Shareholding
13th Mar 20237:00 amRNS2022 Annual Financial Report
10th Mar 20239:31 amRNSDirectorate Change - Replacement
10th Mar 20239:00 amRNSDirectorate Change
8th Mar 20234:00 pmRNSDirector/PDMR Shareholding
1st Mar 20232:00 pmRNSTotal Voting Rights
7th Feb 20233:45 pmRNSMiscellaneous - PGH/TCS Extension of Partnership
7th Feb 20232:30 pmRNSDirector/PDMR Shareholding
1st Feb 20232:00 pmRNSTotal Voting Rights
6th Jan 20234:30 pmRNSDirector/PDMR Shareholding
30th Dec 20221:00 pmRNSTotal Voting Rights
12th Dec 20224:30 pmRNSBlock listing Interim Review
7th Dec 20224:45 pmRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSTrading Statement
30th Nov 20222:00 pmRNSTotal Voting Rights
8th Nov 20225:30 pmRNSDirector/PDMR Shareholding
31st Oct 20226:00 pmRNSTotal Voting Rights
12th Oct 20224:00 pmRNSDirectorate Change
6th Oct 20224:30 pmRNSDirector/PDMR Shareholding
6th Oct 20224:30 pmRNSDirector/PDMR Shareholding
4th Oct 20224:30 pmRNSHolding(s) in Company
4th Oct 20227:00 amRNSDirector/PDMR Shareholding
30th Sep 20224:30 pmRNSTotal Voting Rights
14th Sep 20224:30 pmRNSDirector/PDMR Shareholding
9th Sep 202211:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.